Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sambhaji Shankar Pisal"'
Publikováno v:
Biologicals. 63:1-13
With the advancements in upstream technologies, the capacity for monoclonal antibody (mAb) production has transformed from a few milligrams to grams per liter. These titers lead to enormous pressure on downstream processes (DSPs), which need to be re
Autor:
Awa Traore, Sambhaji Shankar Pisal, Ray Borrow, Amol Chaudhari, Yuxiao Tang, Prasad S. Kulkarni, Milagritos D. Tapia, Fadima Cheick Haidara, Samba O. Sow, F. Marc LaForce, Dhananjay Kapse, Kelly Townsend-Payne, Rajeev M. Dhere, Lionel Martellet, Nancy Hosken, Mark R. Alderson, Fatoumata Diallo, Igor Smolenov, Abdi Naficy
Publikováno v:
The New England journal of medicine. 384(22)
We conducted a phase 2, observer-blinded, randomized, controlled trial involving Malian children 12 to 16 months of age. Participants were assigned in a 2:2:1 ratio to receive nonadjuvanted NmCV-5, alum-adjuvanted NmCV-5, or the quadrivalent vaccine
Autor:
Rajeev M. Dhere, Eilís Moran, Asha D. Mallya, Fang Gao, Marc LaForce, Lakshmi Khandke, Annamraju D. Sarma, Sameer Manohar Kale, Trusha Desai, Pankaj Sharma, Ida Karin Nordgren, Rory Care, Sushil Patni, Vinay Gavade, Timothy R. Rudd, Sunil Goel, Ian M. Feavers, Mark R. Alderson, Sunil Gairola, Suhas Hattarki, Nikhil Avalaskar, Prashant Bore, Sambhaji Shankar Pisal, Nicola J. Beresford, Neil Ravenscroft, Barbara Bolgiano
Publikováno v:
Pathogens
Pathogens, Vol 10, Iss 928, p 928 (2021)
Volume 10
Issue 8
Pathogens, Vol 10, Iss 928, p 928 (2021)
Volume 10
Issue 8
Towards achieving the goal of eliminating epidemic outbreaks of meningococcal disease in the African meningitis belt, a pentavalent glycoconjugate vaccine (NmCV-5) has been developed to protect against Neisseria meningitidis serogroups A, C, Y, W and
Autor:
Nithya J Gogtay, Prasad S. Kulkarni, Peter S. Cheslock, Rajeev M. Dhere, Varsha Parulekar, B J Mahendra, D H Ashwath Narayana, B R Harish, William C. Blackwelder, Deborah C. Molrine, Renuka Munshi, Dipti Kumbhar, Sambhaji Shankar Pisal, Sunil Karande, Saket J. Thaker, Vikas D. Kshirsagar, Bhagwat Gunale, H S Ravish, Siddharth P Deshpande, Susan M. Moore
Publikováno v:
Clinical Infectious Diseases. 66:387-395
Background Lack of access to rabies immunoglobulin (RIG) contributes to high rabies mortality. A recombinant human monoclonal antibody (SII RMAb) was tested in a postexposure prophylaxis (PEP) regimen in comparison with a human RIG (HRIG)-containing
Autor:
Roger I. Glass, Jagdish Kamalaji Zade, William C. Weldon, Yuhuan Wang, Sambhaji Shankar Pisal, Sung-Sil Moon, Baoming Jiang, Rajeev M. Dhere
Publikováno v:
Vaccine. 37(5)
A parenteral inactivated rotavirus vaccine (IRV) in development could address three problems with current live oral rotavirus vaccines (ORV): their lower efficacy in low and middle-income countries (LMICs), lingering concerns about their association
Autor:
Lionel Martellet, Ray Borrow, Helen Findlow, Valerie Brown, Wilbur H. Chen, Megan L McDonough, C Rebecca Boyce, Mark R. Alderson, Prasad S. Kulkarni, Nancy Hosken, Kathleen M. Neuzil, Rajeev M. Dhere, Mardi Reymann, Marcela F. Pasetti, Len Dally, Sambhaji Shankar Pisal, F. Marc LaForce, Amol Chaudhari
Publikováno v:
The Lancet. Infectious diseases. 18(10)
Summary Background Invasive meningococcal disease is an important public health problem, especially in sub-Saharan Africa. After introduction of MenAfriVac in 2010, Neisseria meningitidis serogroup A disease has been almost eliminated from the region
Autor:
Ravi Menon, Jagdish Kamalaji Zade, Rajeev M. Dhere, Rajendra Narayan Sabale, Sambhaji Shankar Pisal, Sunil Gairola, Sameer P. Naik, Subhash G. Bankar
Publikováno v:
Vaccine. 35(22)
Vaccines currently available across the globe are stored and transported in a continuous cold-chain at 2-8°C or below -20°C. A temperature excursion outside this range affects the potency of the vaccines. Such vaccines need to be discarded leading